Advertisement

Treatment for muscular dystrophy, which typically kills patients by their thirties, has not advanced much since the 1980’s. Wall Street Journal reporter Jonathon Rockoff talks about a new generation of drugs that promises to extend patient’s lives by years or decades.

 

Advertisement
Advertisement